
ONE in America
4.7K posts

ONE in America
@ONEinAmerica
ONE fights for the investments needed to create economic opportunities and healthier lives in Africa.


Hope has arrived. The first shipment of Lenacapavir landed in Kenya last night. Lenacapavir is a game-changing HIV prevention treatment manufactured by Gilead Sciences, an American company, and has the potential to significantly reduce new HIV infections, particularly among pregnant and breastfeeding women. With just two injections a year, Kenyans at risk can protect themselves from HIV and help move the country closer to an AIDS-free generation. The U.S., in partnership with the Global Fund, committed to co-funding the purchase of Lenacapavir for distribution to up to 2 million individuals globally. 🇺🇸 is delivering health innovation that is saving lives.




Ambassador Greer issued a statement following President Trump signing into law legislation that reauthorizes the African Growth and Opportunity Act trade preference program through December 31, 2026, with retroactive effect to September 30, 2025. ustr.gov/about/policy-o…












We're so close to seeing the end of HIV/AIDS in our lifetime. But we all need to work together to cross the finish line. Today’s action: email Congress urging them to continue to invest in programs like @PEPFAR and the @GlobalFund before it’s too late. go.one.org/3LZEJaA








